Region PrintPrint Contact UsContact us Resize text
-A +A
Bookmark and Share
Pursue Life ™Maxx Medical


Contact Us - Maxx Medical

Freedom Knee® Revision Knee System Receives European CE Mark Approval

Maxx Medical to Showcase Freedom® PCK Components During International Congress of Joint Replacement (ICJR) Middle East Meeting

Plymouth Meeting, PA (USA) and Dubai, UAE April 30, 2014 -- Maxx Orthopedics, Inc. a subsidiary of Maxx Medical, Pvt. Ltd., a rapidly expanding global orthopedics device company, today announced that it has received European CE Mark clearance for its Freedom® PCK Components (PCK), the latest addition to its revision knee system.

The Freedom® PCK combines Maxx’s Freedom® Stemmed Tibial Components with patent-pending Femoral Components and Constrained Liners, to create one of the most bone conserving, low profile revision knee systems available on the market.

This complete revision knee replacement system was developed to provide a wide variety of component size and stability configurations, while conserving bone. It offers a constrained option to surgeons whose patients require additional stability, without significantly compromising range of motion and rotation. Following the same design philosophy as Maxx’s Freedom Total Knee® primary system, the revision system adds:

  • Patent-pending progressive constraint, remaining highly constrained in extension and relatively less constrained as the patient increases flexion;
  • A femoral/tibial size range equivalent to the primary knee system and including liner thicknesses up to 31mm, to appeal to global patient and surgeon populations;
  • Interchangeability between Freedom Stemmed Tibial Components and PCK Components, using straight stem extensions and offset adapters for optimal canal fill and component positioning;
  • Simple and reproducible surgical technique, featuring easy, intra-operative component assembly with minimal additional instrumentation.

“We are excited to further extend the reach of our latest progressive design in the Freedom PCK, as part of our revision knee system, to the global surgeon community. Our number-one goal is to continue to develop innovative options for restoring patient mobility, while improving the process overall for both patients and medical professionals,” said Ashesh Shah, CEO, Maxx Medical. “Obtaining CE Mark approval is a key component in expanding doing just that. We’re excited to share the Freedom PCK at ICJR-ME.”

Freedom Knee is a total knee replacement system specifically engineered for high flexion, bone conservation and advanced component size and fit capabilities. Launched in 2009, Freedom Knee received leading analyst group Frost & Sullivan’s “Product Differentiation Excellence Award in Orthopedic Knee Joint Replacement.” Freedom Knee has US FDA, Drugs Controller General of India (DCGI), European CE Mark, and State Food and Drug Administration P.R. China approvals. Freedom Knee is manufactured in the United States.

Maxx will be showcasing the newly approved Freedom PCK Components and Freedom Knee Primary during the ICJR Show, held April 30 - May 2 at the Dubai International Convention and Exhibition Center in Dubai, UAE (Booth #A20).

About Maxx Medical

Maxx Medical Pvt. Ltd. ("Maxx Medical") develops and markets innovative orthopedic medical devices on an international scale. The company is focused on providing state-of-the-art implants and related solutions that best restore patient mobility while accommodating lifestyle, anatomical and economic needs. Maxx Medical is the parent company of Maxx Orthopedics, Inc., the manufacturer of the Freedom Total Knee® System. For general information visit

© 2016. Maxx Medical Pvt Ltd. All rights reserved.
Freedom Knee® is distributed by Maxx Medical Pvt. Ltd. Freedom Knee® is manufactured by Maxx Orthopedics, Inc
FREEDOM, FREEDOM KNEE, PCK, Pursue Life, and Think Outside the Box are Registered Trademarks of Maxx Orthopedics, Inc.
U.S. and foreign patents pending.